The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage

CompletedOBSERVATIONAL
Enrollment

38,499

Participants

Timeline

Start Date

October 28, 2014

Primary Completion Date

March 15, 2016

Study Completion Date

March 15, 2016

Conditions
Atrial Fibrillation
Interventions
DRUG

Observational

Retrospective Chart Review

Trial Locations (1)

40202

Comprehensive Health Insights, Louisville, Louisville

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY